Lydia Dreosti
- Oncology top 10%
- HER2/EGFR in Cancer Research 5
- CAR-T cell therapy research 2
-
- Chronic Lymphocytic Leukemia Research 2
-
- Gastric Cancer Management and Outcomes 3
- Advanced Breast Cancer Therapies 2
- Renal cell carcinoma treatment 2
-
- Endometrial and Cervical Cancer Treatments 2
-
- Lymphoma Diagnosis and Treatment 3
- Co-authors
- Max S. ManoZhimin ShaoHoward A. BurrisMasakazu ToiTetiana TaranZefei JiangQingyuan ZhangKunwei Shen
- Partner nations
- South AfricaUnited KingdomUnited States
In The Last Decade
Lydia Dreosti
20 papers receiving 460 citations
Peers
Comparison fields: 5 of 69
- Oncology 300
- Genetics 61
- Pulmonary and Respiratory Medicine 179
- Cancer Research 75
- Obstetrics and Gynecology 30
Countries citing papers authored by Lydia Dreosti
This map shows the geographic impact of Lydia Dreosti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lydia Dreosti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lydia Dreosti more than expected).
Fields of papers citing papers by Lydia Dreosti
This network shows the impact of papers produced by Lydia Dreosti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lydia Dreosti. The network helps show where Lydia Dreosti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lydia Dreosti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2020 | 30 | |
| 3 | 2019 | 3 | |
| 4 | 2018 | 5 | |
| 5 | 2017 | 5 | |
| 6 | 2017 | 15 | |
| 7 | 2017 | 3 | |
| 8 | 2017 | 5 | |
| 9 | 2016 | 34 | |
| 10 | 2016 | 9 | |
| 11 | 2015 | 9 | |
| 12 | 2015 | 231 | |
| 13 | 2014 | 5 | |
| 14 | 2014 | 3 | |
| 15 | 2013 | 45 | |
| 16 | 2013 | 17 | |
| 17 | Recommendations for the management of adult chronic myeloid leukaemia in South Africa. | 2011 | 4 |
| 18 | 2009 | 5 | |
| 19 | 1994 | 11 | |
| 20 | 1982 | 31 |
About Lydia Dreosti
Lydia Dreosti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Internal Medicine, having authored 20 papers that have together received 472 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (5 papers), Gastric Cancer Management and Outcomes (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Advanced Breast Cancer Therapies (2 papers), Renal cell carcinoma treatment (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), CAR-T cell therapy research (2 papers) and Endometrial and Cervical Cancer Treatments (2 papers). The work is most often cited by research in Oncology (300 citations), Genetics (61 citations) and Pulmonary and Respiratory Medicine (179 citations). Lydia Dreosti has collaborated with scholars based in South Africa, United Kingdom and United States. Frequent co-authors include Max S. Mano, Zhimin Shao, Howard A. Burris, Masakazu Toi, Tetiana Taran, Zefei Jiang, Qingyuan Zhang, Kunwei Shen, Fabrice André and Donggeng Liu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.